On Tuesday, September 29, the National Stock Exchange recorded two significant block deals that propelled the shares of AXISCADES Technologies and TCI Express to new highs. AXISCADES saw 45.49 lakh shares change hands at ₹1,824 per unit, valuing the transaction at ₹829.72 crore. TCI Express recorded a block deal worth ₹29.59 crore, with 6.10 lakh shares traded at an average price of ₹485 per equity share. The identities of the buyers and sellers remain undisclosed.

AXISCADES Technologies shares surged as much as 10% to hit its upper circuit limit at ₹2,067.40 per unit on the NSE on Tuesday, September 29, compared with Monday’s closing price of ₹1,879.50. The scrip has risen more than 9% in the past week and 30% over the month, and it has rallied 54% on a year‑to‑date basis. Its 52‑week high of ₹2,211 was reached on May 11, 2026, while its year‑low of ₹1,063.30 was recorded on January 22, 2026. As of September 29, 2026, the company’s market capitalisation stands at ₹8,793.37 crore.

TCI Express shares gained as much as 20% to hit an intraday high of ₹583.20 per unit on the NSE on Tuesday, as against the previous session’s closing price of ₹486 per share. At around 12:13 PM, the stock was trading 15.86% higher at ₹563.10 per equity share. It has advanced 16% in the past week and 2% over the month, but on a year‑to‑date basis it has declined 4%. The scrip’s 52‑week high of ₹746.75 was reached on September 30, 2026, while its year‑low of ₹447.55 was touched on March 27, 2026. As of September 29, 2026, its market capitalisation is ₹2,167.29 crore.

A block deal refers to large trades executed through a single transaction of a minimum order size of ₹10 crore. Such deals can only be carried out within the specified block deal window on the stock exchanges. The block deals recorded today were the first session of the window, and the trades were executed in the morning session. The buyers and sellers in both deals are not yet known, leaving the market to speculate on the parties involved.

These block deals contributed to a broader market rally, with Nifty Pharma stocks such as Mankind, Dr Reddy and Gland Pharma lifting the index over 1% after the United States exempted certain drugs from 100% tariffs. The block deal activity, however, was limited to the two companies and did not affect other sectors directly. Investors remain cautious as the identities of the parties in the block deals are still undisclosed, and the market watches for further disclosures that could influence trading volumes and price movements.